Characterization of two distinct alpha-adrenoceptor binding sites in smooth muscle cell membranes from rat and bovine aorta.
In order to characterize postjunctional alpha adrenoceptor binding sites of aortic smooth muscle, the specific binding of (3H)prazosin and (3H)yohimbine to membranes prepared from the medial layers of rat and bovine thoracic aorta was investigated. Binding of (125I)-BE 2254 (2-[B-(4-hydroxyphenyl)-ethylaminomethyl] tetralone) and (3H)RX 781094 (idazoxan) was also examined in bovine membranes. Each of the ligands displayed saturable, specific binding to a single population of sites; the KD values of the respective ligands were similar in the two animal species. The number of (3H)prazosin and (125I)BE 2254 binding sites (160-190 fmol X mg protein-1 in the two species) was higher than the number of (3H)yohimbine and (3H)RX 781094 binding sites (110-120 fmol X mg protein-1 in the bovine and 50 fmol X mg protein-1 in the rat). Alpha-adrenoceptor ligands inhibited binding of the ligands with the following orders of potency:prazosin greater than BE 2254 greater than yohimbine greater than RX 781094 greater than clonidine in the case of (3H)-prazosin, and yohimbine greater than RX 781094 greater than clonidine greater than prazosin in the case of (3H)yohimbine. Methoxamine, in concentrations up to 10 microM, was without effect on the binding of either ligand. The absence or presence of Na+, K+ or Ca2+ added at physiological concentrations did not change the order of potency of displacing ligands whereas Ca2+ reduced by 50% the numbers of (3H)prazosin and (3H)-yohimbine sites and Na+ increased by 3-fold the affinity of (3H)yohimbine.(ABSTRACT TRUNCATED AT 250 WORDS)
Descombes
J J
JJ
Stoclet
J C
JC
D000316:Adrenergic alpha-Agonists / Q000378:metabolism; D000317:Adrenergic alpha-Antagonists / Q000378:metabolism; D000818:Animals; D001011:Aorta / Q000378:metabolism; D001667:Binding, Competitive; D002417:Cattle; D066298:In Vitro Techniques; D007700:Kinetics; D009131:Muscle, Smooth, Vascular / Q000378:metabolism*; D011224:Prazosin / Q000378:metabolism; D051381:Rats; D011942:Receptors, Adrenergic, alpha / Q000378:metabolism*; D012508:Sarcolemma / Q000378:metabolism; D015016:Yohimbine / Q000378:metabolism
D000316:Adrenergic alpha-Agonists; D000317:Adrenergic alpha-Antagonists; D011942:Receptors, Adrenergic, alpha; D015016:Yohimbine; D011224:Prazosin